In the last trading session, 6,060,956 T2 Biosystems, Inc.(NASDAQ:TTOO) shares changed hands as the company’s beta touched 0.68. With the company’s per share price at $1.24 changed hands at -$0.01 or -0.01% during last session, the market valuation stood at $183.47 Million. TTOO’s last price was a discount, traded about -86.29% off its 52-week high of $2.31. The share price had its 52-week low at $0.235, which suggests the last value was 81.05% up since then. When we look at T2 Biosystems, Inc.’s average trading volume, we note the 10-day average is 6.53 Million shares, with the 3-month average coming to 3.48 Million.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Analysts gave the T2 Biosystems, Inc. (TTOO) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.4. If we narrow down to specifics, the data shows that none out of 5 analysts rate the stock as a Sell, with a further none assigning it an Overweight rating. Of the remaining, none recommended TTOO as a Hold, 5 felt it is a Buy and none rated the stock as Underweight. T2 Biosystems, Inc.’s EPS for the current quarter is expected to be -$0.07.

Although TTOO has turned red as seen at the end of in last trading. With action -0.8%, the performance over the past five days has been green. The jump to weekly highs of $1.35 on Wednesday, Dec 30 added 8.15% to the stock’s daily price. The company’s shares are showing year-to-date upside of 0.06%, with the 5-day performance at 0.06% in the green. However, in the 30-day time frame, T2 Biosystems, Inc. (NASDAQ:TTOO) is 0.12% up. Looking at the short shares, we see there were 8.07 Million shares sold at short interest cover period of 2.32 days.

The consensus price target for the stock as assigned by Wall Street analysts is $3.22, meaning bulls need an upside of 159.68% from its current market value. According to analyst projections, TTOO’s forecast low is $2.5 with $4 as the target high. To hit the forecast high, the stock’s price needs a +222.58% upsurge from its current level, while the stock would need to tank 101.61% for it to hit the projected low.

T2 Biosystems, Inc. (TTOO) estimates and forecasts

Data shows that the T2 Biosystems, Inc. share is not performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value dive -11.43% over the past 6 months, a -70.77% in annual growth rate that is considerably lower than the industry average of 14.6%. Moreover, analysts have looked to higher expectations by upgrading its fiscal year 2021 revenue estimates. The rating firms predict current quarter revenue for T2 Biosystems, Inc. will rise +75.9%, while the growth in revenue is estimated to hit 72.7% for the next quarter. Year-over-year growth is forecast to reach 131.8% up from the last financial year.

Consensus estimates given by 5 financial analysts project the company’s revenue in the current quarter to hit an average of $9.01 Million. 4 analysts are of the opinion that T2 Biosystems, Inc.’s revenue for the quarter ending March 01, 2021 will be $9.61 Million. The company’s revenue for the corresponding quarters a year ago was $3.07 Million and $2.63 Million respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 193.6%. The estimates for the next quarter sales put growth at 265.4%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 20.7%. The 2021 estimates are for T2 Biosystems, Inc. earnings to decrease by -2.8%, but the outlook for the next 5-year period is at 0% per year.

T2 Biosystems, Inc. (NASDAQ:TTOO)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 4.81% of T2 Biosystems, Inc. shares while 12.72% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 13.36%. There are 67 institutions holding the T2 Biosystems, Inc. stock share, with Vanguard Group, Inc. (The) the top institutional holder. As of Sep 29, 2020, the company held 3.63% of the shares, roughly 5.36 Million TTOO shares worth $7.3 Million.

Goldman Sachs Group, Inc. holds the second largest percentage of outstanding shares, with 2.95% or 4.36 Million shares worth $5.93 Million as of Sep 29, 2020.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Among Mutual Funds, the top two as of Sep 29, 2020 were Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. With 3331606 shares estimated at $4.53 Million under it, the former controlled 2.25% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.93% of the shares, roughly 1.38 Million shares worth around $1.88 Million.


A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on..

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets are already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
.

Sponsored